Andrea Tham1,2, Dominic Lullo1,3, Sarah Dalton1,4, Siyang Zeng1,4, Ian van Koeverden5, Mehrdad Arjomandi1,4,6. 1. a Department of Medicine , San Francisco Veterans Affairs Medical Center , San Francisco , CA , USA. 2. b Keck School of Medicine , University of Southern California , Los Angeles , CA , USA. 3. c Chicago Medical School , Rosalind Franklin University , North Chicago , IL , USA. 4. d Human Exposure Laboratory, Division of Occupational and Environmental Medicine, Department of Medicine , University of California , San Francisco , CA , USA. 5. e Laboratory of Experimental Cardiology, Division of Heart and Lungs , University Medical Center Utrecht , Utrecht , The Netherlands. 6. f Division of Pulmonary, Critical Care, Allergy and Immunology, and Sleep Medicine, Department of Medicine , University of California , San Francisco , CA , USA.
Abstract
BACKGROUND: Epidemiologic studies have linked inhalation of air pollutants such as ozone to cardiovascular mortality. Human exposure studies have shown that inhalation of ambient levels of ozone causes airway and systemic inflammation and an imbalance in sympathetic/parasympathetic tone. METHODS: To explore molecular mechanisms through which ozone inhalation contributes to cardiovascular mortality, we compared transcriptomics data previously obtained from bronchoalveolar lavage (BAL) cells obtained from healthy subjects after inhalational exposure to ozone (200 ppb for 4 h) to those of various cell samples from 11 published studies of patients with atherosclerotic disease using the Nextbio genomic data platform. Overlapping gene ontologies that may be involved in the transition from pulmonary to systemic vascular inflammation after ozone inhalation were explored. Local and systemic enzymatic activity of an overlapping upregulated gene, matrix metalloproteinase-9 (MMP-9), was measured by zymography after ozone exposure. RESULTS: A set of differentially expressed genes involved in response to stimulus, stress, and wounding were in common between the ozone and most of the atherosclerosis studies. Many of these genes contribute to biological processes such as cholesterol metabolism dysfunction, increased monocyte adherence, endothelial cell lesions, and matrix remodeling, and to diseases such as heart failure, ischemia, and atherosclerotic occlusive disease. Inhalation of ozone increased MMP-9 enzymatic activity in both BAL fluid and serum. CONCLUSIONS: Comparison of transcriptomics between BAL cells after ozone exposure and various cell types from patients with atherosclerotic disease reveals commonly regulated processes and potential mechanisms by which ozone inhalation may contribute to progression of pre-existent atherosclerotic lesions.
BACKGROUND: Epidemiologic studies have linked inhalation of air pollutants such as ozone to cardiovascular mortality. Human exposure studies have shown that inhalation of ambient levels of ozone causes airway and systemic inflammation and an imbalance in sympathetic/parasympathetic tone. METHODS: To explore molecular mechanisms through which ozone inhalation contributes to cardiovascular mortality, we compared transcriptomics data previously obtained from bronchoalveolar lavage (BAL) cells obtained from healthy subjects after inhalational exposure to ozone (200 ppb for 4 h) to those of various cell samples from 11 published studies of patients with atherosclerotic disease using the Nextbio genomic data platform. Overlapping gene ontologies that may be involved in the transition from pulmonary to systemic vascular inflammation after ozone inhalation were explored. Local and systemic enzymatic activity of an overlapping upregulated gene, matrix metalloproteinase-9 (MMP-9), was measured by zymography after ozone exposure. RESULTS: A set of differentially expressed genes involved in response to stimulus, stress, and wounding were in common between the ozone and most of the atherosclerosis studies. Many of these genes contribute to biological processes such as cholesterol metabolism dysfunction, increased monocyte adherence, endothelial cell lesions, and matrix remodeling, and to diseases such as heart failure, ischemia, and atherosclerotic occlusive disease. Inhalation of ozone increased MMP-9 enzymatic activity in both BAL fluid and serum. CONCLUSIONS: Comparison of transcriptomics between BAL cells after ozone exposure and various cell types from patients with atherosclerotic disease reveals commonly regulated processes and potential mechanisms by which ozone inhalation may contribute to progression of pre-existent atherosclerotic lesions.
Authors: Michael L Paffett; Katherine E Zychowski; Lianne Sheppard; Sarah Robertson; John M Weaver; Selita N Lucas; Matthew J Campen Journal: Toxicol Sci Date: 2015-05-11 Impact factor: 4.849
Authors: Urmila P Kodavanti; Ronald Thomas; Allen D Ledbetter; Mette C Schladweiler; Jonathan H Shannahan; J Grace Wallenborn; Amie K Lund; Matthew J Campen; Elizabeth O Butler; Reddy R Gottipolu; Abraham Nyska; Judy E Richards; Deborah Andrews; Richard H Jaskot; John McKee; Sainath R Kotha; Rishi B Patel; Narasimham L Parinandi Journal: Environ Health Perspect Date: 2010-10-27 Impact factor: 9.031
Authors: James G Wagner; Katryn Allen; Hui-yu Yang; Bin Nan; Masako Morishita; Bhramar Mukherjee; J Timothy Dvonch; Catherine Spino; Gregory D Fink; Sanjay Rajagopalan; Qinghua Sun; Robert D Brook; Jack R Harkema Journal: Environ Health Perspect Date: 2013-10-29 Impact factor: 9.031
Authors: Ekaterina Mostovenko; Tamara Young; Pretal P Muldoon; Lindsey Bishop; Christopher G Canal; Aleksandar Vucetic; Patti C Zeidler-Erdely; Aaron Erdely; Matthew J Campen; Andrew K Ottens Journal: Part Fibre Toxicol Date: 2019-05-29 Impact factor: 9.400